Y. Shimizu

Pharmacological and pharmacokinetic study of olmesartan medoxomil in animal diabetic retinopathy models.

Tatsuya Inoue, N. Arakawa, Y. Yoshigae, 2005, European journal of pharmacology.

Oral administration of a centrally acting ghrelin receptor agonist to conscious rats triggers defecation

A. Muir, S. Butler, G. Sanger, 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Functional and in situ hybridization evidence that preganglionic sympathetic vasoconstrictor neurons express ghrelin receptors

G. Sanger, J. Furness, P. Kitchener, 2010, Neuroscience.

[Pharmacological study of mequitazine (LM-209) (II). Anti-allergic action (author's transl)].

H. Fujimura, K. Tsurumi, Y. Hiramatsu, 1981, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Novel monoamine oxidase inhibitors, 3-(2-aminoethoxy)-1,2-benzisoxazole derivatives, and their differential reversibility.

I. Kaneko, Y. Shimizu, M. Kozuka, 2002, Japanese journal of pharmacology.

Effects of NMDA receptor antagonists on visceromotor reflexes and on intestinal motility, in vivo

P. Kitchener, G. Sanger, A. Shafton, 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

The anti-overactive bladder activity of KW-7158 is mediated by blocking equilibrative nucleoside transporter-1.

Tetsuo Yoshida, T. Sakuma, Hidetaka Sato, 2014, Biological & pharmaceutical bulletin.

The pathophysiological functions mediated by D1 dopamine receptors.

M. Goldstein, E. Meller, S. Kuga, 1986, Advances in experimental medicine and biology.